journal
https://read.qxmd.com/read/38558899/symptom-intensity-of-post-covid-and-long-covid-syndromes-in-patients-entering-rehabilitation-treatment
#1
JOURNAL ARTICLE
Jan Ceklarz
INTRODUCTION: The problem of post-COVID symptoms is still being analysed. Many of them may be related to other conditions, but the new appearance and greater intensity of some of them, e.g. fatigue, musculoskeletal pain, and neuropathic pain, seem to be related to a previous viral infection. Efforts are being made to determine in more detail the most characteristic symptoms of post-COVID syndrome. The conditions of rehabilitation after COVID-19 provide an opportunity for such observations...
2024: Reumatologia
https://read.qxmd.com/read/38558898/autoimmune-rheumatic-diseases-and-covid-19-vaccination-a-retrospective-cross-sectional-study-from-astana
#2
JOURNAL ARTICLE
Kristina Rutskaya-Moroshan, Saule Abisheva, Madina Sarsenova, Vyacheslav Ogay, Tatyana Vinnik, Bakyt Aubakirova, Anilim Abisheva
INTRODUCTION: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has had an unprecedented impact on people around the world, particularly those who were suffering from autoimmune rheumatic diseases (AIRDs). The world community acknowledges the significance of COVID-19 vaccination in patients with autoimmune disorders and emphasizes the priority of this category to receive vaccination over the general population. Although many studies have been published since the first phases of vaccination all over the world, multiple related factors still need to be further investigated...
2024: Reumatologia
https://read.qxmd.com/read/38558897/dual-energy-x-ray-absorptiometry-is-it-the-gold-standard-or-is-bone-mineral-density-everything
#3
EDITORIAL
Paweł Żuchowski, Daniel Jeka
No abstract text is available yet for this article.
2024: Reumatologia
https://read.qxmd.com/read/38558896/burden-of-disease-pain-catastrophizing-and-central-sensitization-in-relation-to-work-related-issues-in-young-spondyloarthritis-patients
#4
JOURNAL ARTICLE
Aicha Ben Tekaya, Hanene Ben Said, Imene Yousfi, Siwar Ben Dhia, Selma Bouden, Leila Rouached, Ines Mahmoud, Rawdha Tekaya, Olfa Saidane, Leila Abdelmoula
INTRODUCTION: Spondyloarthritis (SpA) is a common rheumatic inflammatory disease and can impact patients' work productivity. We aimed to evaluate the impact of pain catastrophizing and central sensitization on work outcomes in young SpA patients and determine the predictive factors of work productivity loss. MATERIAL AND METHODS: We performed a cross-sectional study over 6 months. We included patients aged between 18 and 50 years old, diagnosed with axial or peripheral SpA...
2024: Reumatologia
https://read.qxmd.com/read/38558895/a-three-stage-concept-of-spine-pathology-treatment-a-different-perspective
#5
REVIEW
Kamil Koszela
Spinal pathologies develop in patients of all ages and may have various underlying factors. These factors include, among others, myofascial pain syndromes, disc herniation and spinal degeneration. Treatment alone, both causal and symptomatic, is not always sufficient in certain situations. The aim of this paper is to discuss the question of comprehensive treatment of spine pathologies focusing on a three-stage treatment concept. An important aspect is to determine the risk factors and their reduction, or at least modification, i...
2024: Reumatologia
https://read.qxmd.com/read/38558894/autoimmune-diseases-and-myelodysplastic-syndromes
#6
REVIEW
Arij Cheffai, Melek Kechida
Autoimmune diseases (ADs) and myelodysplastic syndrome (MDS) may be associated in approximately 10-20% of cases. Although this association has been well recognized, it is not always easily diagnosed. The exact physiopathological mechanism involved has yet to be determined but seems to be multifactorial. The therapeutic decision is not well codified and often represents a challenge. But overall, glucocorticosteroids have generally proven to be effective at the expense of a high incidence of dependence and relapse...
2024: Reumatologia
https://read.qxmd.com/read/38558893/covid-19-prophylaxis-diagnostics-and-treatment-in-patients-with-rheumatic-diseases-the-polish-experts-panel-opinion
#7
JOURNAL ARTICLE
Brygida Kwiatkowska, Magdalena Krajewska-Włodarczyk, Bogdan Batko, Maria Maślińska, Marcin Stajszczyk, Jerzy Świerkot, Piotr Wiland, Zbigniew Żuber, Krzysztof Tomasiewicz
As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolves, infection management in vulnerable populations requires formalized guidance. Although low-virulence variants of SARS-CoV-2 remain predominant, they pose an increased risk of severe illness in adults with rheumatic and musculoskeletal diseases (RMDs). Several disease-specific (chronic long-grade inflammation, concomitant immunosuppression) and individual (advanced age, multimorbidity, pregnancy, vaccination status) factors contribute to excess risk in RMD populations...
2024: Reumatologia
https://read.qxmd.com/read/38558892/the-state-of-bone-mineral-density-in-men-with-ankylosing-spondylitis-and-its-relationship-with-the-course-of-the-disease
#8
JOURNAL ARTICLE
Sergii Shevchuk, Oksana Pavliuk
INTRODUCTION: The aim of the study was to study the structural and functional state of bone tissue in men with ankylosing spondylitis (AS) and to assess its relationship with the course of the disease. MATERIAL AND METHODS: A study was conducted with the participation of 105 men with AS aged from 22 to 59 years (average age was 40.7 ±0.8 years) with a duration of the disease of 8.7 ±0.5 years and 29 persons of the control group. Disease activity and the degree of functional limitations were determined by the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Ankylosing Spondylitis Activity Score correlated with C-reactive protein (ASDAS-CRP) and the Bath Ankylosing Spondylitis Functional Index (BASFI)...
2024: Reumatologia
https://read.qxmd.com/read/38558891/comparison-of-ankylosing-spondylitis-disease-activity-score-and-bath-ankylosing-spondylitis-disease-activity-index-tools-in-assessment-of-axial-spondyloarthritis-activity
#9
REVIEW
Katarzyna Wiąk-Walerowicz, Ewa Wielosz
Axial spondyloarthritis (axSpA) is an inflammatory joint disease, in which the dominant symptom is inflammatory back pain. It affects approximately 1% of the population, with a higher incidence in males. Spinal pain associated with spondyloarthritis is referred to as inflammatory back pain. In clinical practice, it is extremely important to be able to assess the activity of inflammatory back diseases and to select appropriate treatment and monitor the therapy. Currently, two main tools are used for assessment of the activity of axial spondyloarthritis: BASDAI (Bath Ankylosing Spondylitis Disease Activity Index) and ASDAS (Ankylosing Spondylitis Disease Activity Score)...
2024: Reumatologia
https://read.qxmd.com/read/38322108/autoimmunity-and-long-covid-in-children
#10
Oksana Boyarchuk, Liubov Volianska
Numerous hypotheses regarding the pathogenetic mechanisms of long COVID have been proposed. Immune dysregulation and autoimmunity are among the leading hypotheses. In this article, we present two clinical cases of long COVID. The first case demonstrates the phenotype of long COVID with pain and musculoskeletal symptoms, which is often associated with autoimmunity and mimics systemic connective tissue diseases. In the second case, a high titer of antinuclear antibodies was observed after SARS-CoV-2 infection, but the clinical symptoms were limited to fever and headache...
2023: Reumatologia
https://read.qxmd.com/read/38322107/monitoring-of-the-pharmacological-treatment-availability-in-patients-with-multiple-sclerosis-in-the-greater-poland-population
#11
REVIEW
Przemysław Daroszewski, Katarzyna Kaczmarek, Juliusz Huber
INTRODUCTION: There is no clear explanation for the availability of multiple sclerosis (MS) pharmacological treatment for patients in Greater Poland and it can be assumed that the same reason is common in most of the developed countries in the United Europe. As an autoimmune disease MS can overlap with other diseases especially rheumatic disease (RD) as well as some feature of RD may mimic MS, such as MS-like syndrome in the course of primary Sjögren's syndrome. Therefore proper diagnosis and sufficient treatment of MS is important not only for neurologists but also for other clinicians including rheumatologists...
2023: Reumatologia
https://read.qxmd.com/read/38322106/rheumatoid-arthritis-medication-dosage-in-chronic-kidney-disease
#12
REVIEW
Kinga Maria Tyczyńska, Hanna Augustyniak-Bartosik, Jerzy Świerkot
Renal failure in the course of rheumatoid arthritis (RA) is a consequence of many factors, including drug-induced nephrotoxicity, comorbidities and chronic inflammation. Contemporary treatment strategies have reduced the incidence of renal failure in the population of RA patients. However, it remains a problem for approximately 25% of patients. Therefore, special attention should be paid to the potential need for dosage modifications of administered medications. Many drugs used in the therapy of rheumatic diseases have not been thoroughly studied for their safety in patients with reduced glomerular filtration, resulting in limited data in this area...
2023: Reumatologia
https://read.qxmd.com/read/38322105/musculoskeletal-disorders-and-their-associated-factors-among-individuals-with-diabetes-mellitus-in-northwest-nigeria
#13
JOURNAL ARTICLE
Halima Ibrahim Hassan, Bashir Kaka, Kolade Oladele Sharaye, Umar Abdulaziz, Aisha Sada, Francis Fatoye, Aminu Alhassan Ibrahim
INTRODUCTION: Diabetes mellitus (DM) is a growing public health problem causing a significant amount of disability and mortality in Nigeria. Musculoskeletal disorders (MSDs) are common complications associated with DM. However, studies on the prevalence of MSDs and their associated factors are limited in Nigeria, particularly in the northwest region. The purpose of this study was to determine the prevalence of MSDs and their associated factors among individuals with DM in northwest, Nigeria...
2023: Reumatologia
https://read.qxmd.com/read/38322104/coronary-artery-lesions-in-takayasu-arteritis
#14
REVIEW
Marta Dzhus, Halyna Mostbauer
INTRODUCTION: Takayasu arteritis (TAK) is a granulomatous inflammation of vessels of large diameter, mainly affecting the aorta and its proximal branches, which is more common in young women. The incidence of coronary artery disease in TAK is unknown and not sufficiently studied. MATERIAL AND METHODS: A literature review was performed for the period 2003 to 2023 using a search of the PubMed and Scopus scientific databases. We used the following key words to search the academic journal databases: "Takayasu arteritis", "coronary angiography", "myocardial revascularization", "coronary artery disease", "angina pectoris", and "myocardial infarction"...
2023: Reumatologia
https://read.qxmd.com/read/38322103/presence-of-subclinical-giant-cell-arteritis-in-patients-with-morning-stiffness-of-duration-less-than-45-minutes-at-the-time-of-diagnosis-of-polymyalgia-rheumatica
#15
JOURNAL ARTICLE
Ciro Manzo, Alberto Castagna, Nicola Veronese, Marco Isetta
INTRODUCTION: In some patients with polymyalgia rheumatica (PMR), giant cell arteritis (GCA) is subclinical as underlying inflammation of large vessels (LV) is present without evidence of related clinical manifestations. Different factors have been proposed as predictive of subclinical GCA in PMR patients. To date, the literature reports scant data about the association between subclinical GCA and long-lasting morning stiffness (MS) in patients at the time of diagnosis of PMR. Given this background, the aim of this study was to assess the association between subclinical GCA and MS < 45 min in patients with newly diagnosed PMR...
2023: Reumatologia
https://read.qxmd.com/read/38322102/on-the-role-of-anti-cn1a-antibodies-in-sporadic-inclusion-body-myositis-and-beyond-a-challenging-task-full-of-surprises
#16
EDITORIAL
Eleni Patrikiou, Christos Liaskos, Dimitrios P Bogdanos
No abstract text is available yet for this article.
2023: Reumatologia
https://read.qxmd.com/read/38322101/multicenter-evaluation-of-tofacitinib-retention-and-safety-in-rheumatoid-arthritis-why-cardiovascular-risk-factors-do-not-equate-to-overt-risk
#17
JOURNAL ARTICLE
Anna Felis-Giemza, Mateusz Moskal, Krzysztof Proc, Zbigniew Guzera, Marcin Stajszczyk, Karolina Palej, Kornelia Chmurzyńska, Piotr Wiland, Krzysztof Batko, Bogdan Batko
INTRODUCTION: This multicenter, real-world, retrospective cohort study aimed to assess the effectiveness and safety of tofacitinib (TOFA) in rheumatoid arthritis (RA). MATERIAL AND METHODS: Two hundred nine patients with active RA treated with TOFA, unresponsive to at least 2 conventional synthetic disease-modifying drugs, were recruited. Clinical characteristics were extracted from an electronic registry and supplemented with manual chart review and data linkage with ambulatory care...
2023: Reumatologia
https://read.qxmd.com/read/38322100/scleroderma-overlap-syndromes-capillaroscopy-laboratory-and-clinical-manifestations-and-follow-up-compared-to-scleroderma-patients
#18
JOURNAL ARTICLE
Saeedeh Shenavandeh, Zahra Azariyon, Mohammad Ali Nazarinia
INTRODUCTION: Overlap syndrome (OS) is a group of systemic connective tissue diseases (CTDs) that meet the criteria of two or more CTDs. In this study, we evaluated clinical, laboratory, and capillaroscopic manifestations of patients with scleroderma OS (SSc-OS) and its subgroups and follow-up progression compared to patients with limited SSc (LcSSc). MATERIAL AND METHODS: In a 10-year cross-sectional study, we evaluated 135 adult patients (70 with SSc-OS and 65 with LcSSc) with the same skin score for their baseline and follow-up clinical, laboratory, high-resolution chest tomography (HRCT), echocardiography, and nailfold capillaroscopy data and compared them...
2023: Reumatologia
https://read.qxmd.com/read/38322099/newly-developed-cardiovascular-risk-factors-in-rheumatoid-arthritis-patients-initiating-biologic-treatment
#19
JOURNAL ARTICLE
Wojciech Zaręba, Piotr Krawiec, Małgorzata Banaszkiewicz, Krzysztof Batko, Aleksandra Gołąb, Dariusz Plicner, Zbigniew Żuber, Bogdan Batko
INTRODUCTION: Rheumatoid arthritis (RA) is a risk factor (RF) for cardiovascular (CV) disease, a leading cause of mortality in RA patients. MATERIAL AND METHODS: Consecutive records of RA patients with high disease activity screened upon biologic therapy initiation were reviewed between January 2001 and 2018. Patients with at least 6-month follow-up and baseline disease activity scores were enrolled ( n = 353) and stratified into manifest CV disorder ("overt CVD"), any traditional CV risk factor ("atCVrisk") and no CV risk factor ("vlCVrisk") groups...
2023: Reumatologia
https://read.qxmd.com/read/37970123/temporomandibular-joint-disorders-in-seronegative-spondyloarthritis-what-a-rheumatologist-needs-to-know
#20
REVIEW
Vasiliki Syrmou, Maria G Grammatikopoulou, Dimitrios P Bogdanos, Konstantinos T Mitsimponas
Temporomandibular joint (TMJ) can be affected in the context of spondyloarthritis (SpA) with detrimental impact on individuals' quality of life. Intra-articular inflammation, synovitis, enthesitis, disc displacement and cervical vertebrae malalignment are some of the pathophysiological phenomena involved. Temporomandibular joint disorders (TMD) incidence appears to be higher in patients with ankylosing spondylitis and psoriatic arthritis, especially when clinical evaluation includes not only imaging but relevant history, TMJ examination and diagnostic criteria for TMD...
2023: Reumatologia
journal
journal
45754
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.